NEW YORK (GenomeWeb) – Trovagene announced on Monday night that it has fired its CEO Antonius Schuh and CFO Stephen Zaniboni, alleging that the two executives failed to present the company with a lucrative opportunity for a new therapeutic, and instead took the opportunity for their own personal benefit.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.